Choice Architecture and Colorectal Cancer Screening Outreach

Completed · Not applicable

Conditions studied: Cancer of Colon

In brief

This pilot study is a 3-arm randomized control trial assessing the effectiveness of sequential or active choice in CRC (colorectal cancer) screening outreach vs. colonoscopy outreach only, in patients between 50-74 years old, who have received care at the University City or Valley Forge CCA (Community Care Associates) practices, are due for screening, and are asymptomatic for CRC. The three arms are: Arm 1: Direct schedule colonoscopy (Control), Arm 2: Direct schedule colonoscopy followed by mailed FIT(Fecal Immunochemical Test) (Sequential Choice), and Arm 3: Choice of direct schedule colonoscopy or mailed FIT (Active Choice).

Key facts

Study ID

NCT03246438

Run by

University of Pennsylvania

People needed

423

Starts

2017-11-14

Expected to finish

2018-07-14

Last updated by the study team

2019-02-20

Who can join

Age: 50 and older, up to 74. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Between 50 and 74 years old
• Has a primary care provider who is a University City or Valley Forge Family Medicine provider
• Has had at least 2 office visits at either practice
• Is due for colorectal cancer screening
• Is asymptomatic for CRC
• Subject's zip code is within the Philadelphia-Wilmington-Camden Metropolitan Statistical Area

You may not qualify if…

• Has had prior colonoscopy within 10 years, sigmoidoscopy within 5 years, or FOBT/FIT within twelve months of chart review (we will exclude patients who self-report any of the above procedures)
• Has a history of CRC or colonic polyps
• Has a history of GI cancer
• Has a history of confirmed Inflammatory Bowel Disease (IBD)
• has a history of colitis other than Crohns disease or ulcerative colitis)
• Has a first degree relative that has been diagnosed with CRC
• Has had a colectomy
• Has been diagnosed with Familial Adenomatous Polyposis (FAP)
• Has been diagnosed with Lynch Syndrome (i.e. HNPCC)
• Has iron-deficiency anemia
• Has a history of lower GI bleeding
• Has metastatic (Stage IV) blood or solid tumor cancer
• Has end stage renal disease
• Has cirrhosis
• Has heart failure
• Has dementia
• Has any other condition that, in the opinion of the investigator, excludes the patient from participating in this study

Where it is running

• University of Pennsylvania Health System — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.